EAEkaterina-Iva A. Adamanskaya

Ekaterina-Iva A. Adamanskaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekaterina-Iva A. Adamanskaya has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Granulomatosis with polyangiitis: functional activity of neutrophils and spontaneous NETosis (clinical case)

    by Tatiana M. Reshetnyak, Evgeniya N. Vorkel, Kamila S. Nurbaeva, Ekaterina-Iva A. Adamanskaya, Sofia V. Galkina, Anastasia N. Sveshnikova, Aleksander M. Lila

    The clinical significance of neutrophil activation and NETosis in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is the focus of ongoing research. In the presented clinical case of active granulomatosis with polyangiitis (GPA) with multi-organ damage associated with ANCA-proteinase 3 (PR3), a high proportion of neutrophils transitioning to NETosis (97.9%) was detected. This case report aimed to characterize spontaneous NETosis and neutrophil functional activity in a patient with severe active PR3-positive GPA in order to determine whether a distinct pattern of neutrophil activation could be identified. In this case, NETosis was completely represented by the suicidal variant, with no evidence of vital NETosis or extracellular DNA structures formed by other leukocytes. This observation adds to the current understanding of the key role of neutrophils and NETs in the pathogenesis of AAV. Unlike previous studies that mainly quantified circulating NET markers or stimulated NET formation in vitro, this report provides an integrated assessment of spontaneous NETosis phenotype together with neutrophil chemotaxis and thromboinflammatory behavior in an individual patient with active GPA.

  • Open Access

    Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6 ‐related thrombocytopenia

    by Ivan P. Tesakov, Julia‐Jessica D. Korobkin, Daria V. Fedorova, Sofia V. Galkina, Maria M. Golomysova, Sergei I. Obydennyi, Anastasia A. Ignatova, Ekaterina‐Iva A. Adamanskaya, Eugenia V. Yushkova, Anna V. Pavlova, et al.

    Summary: ETV6‐related thrombocytopenia (ETV6‐RT) is an inherited platelet disorder caused by germline ETV6 variants. Despite recent progress, the mechanisms underlying platelet dysfunction in ETV6‐RT remain unclear. We investigated 12 patients from six families using functional assays, electron microscopy, quantitative proteomics and cytoskeletal imaging. Most patients exhibited mild‐to‐moderate thrombocytopenia with variable paediatric bleeding symptoms (median International Society on Thrombosis and Haemostasis Bleeding Assessment Tool 3, range 1–9) but consistently mild bleeding in adulthood (median 0, range 0–1). Ex vivo thrombus formation was reduced independent of platelet count. Electron microscopy revealed defective platelet shape maintenance, characterized by spheroid morphology, reduced D max / D min ratios and diminished alpha‐granule pools. Flow cytometry and single‐platelet total internal reflection fluorescence imaging demonstrated largely preserved calcium signalling but impaired activation‐dependent shape change, dense‐granule release and integrin activation. Proteomics showed reduced alpha‐granule and lysosomal proteins alongside imbalanced regulators of actin remodelling and β‐tubulin. Phalloidin staining confirmed impaired actin cytoskeletal remodelling with reduced lamellipodia formation, while immunofluorescence revealed abnormal β1‐tubulin localization with disrupted marginal bands and reduced lysosome‐associated membrane protein 1 (LAMP1) expression. Additionally, granulocyte recruitment and migration within thrombi were impaired, suggesting broader thromboinflammatory defects. These findings suggest that combined disruption of cytoskeletal integrity and granule biogenesis underlies impaired thrombus formation in ETV6‐RT, providing mechanistic insight into the haemostatic defects associated with this disorder.


  • Open Access

    NETosis and Neutrophil Activity Quantification in Pediatric Patients with Essential Thrombocythemia

    by Ekaterina-Iva A. Adamanskaya, Julia-Jessica D. Korobkin, Alexey V. Pshonkin, Alexey V. Bogdanov, Sofia V. Galkina, Nadezhda A. Podoplelova, Eugenia V. Yushkova, Mikhail A. Panteleev, Galina A. Novichkova, Nataliya S. Smetanina, et al.

    Elevated levels of neutrophil extracellular traps (NETs) are associated with thrombotic risks, in particular, for patients with elevated platelet counts, such as those with essential thrombocythemia (ET). Here, the tendency for NETosis and neutrophil activity in such patients was assessed. A total of forty-one pediatric patients with elevated platelet counts diagnosed with ET (nine with CALR driver mutation, eleven with JAK2, thirteen triple-negative, and one dual-negative (TN)) or secondary thrombocytosis (five) were recruited. The tendency for NETosis was determined in a leucocyte-rich blood plasma smear using immunofluorescence staining with antibodies against myeloperoxidase and elastase. Activity of neutrophils was assessed ex vivo in parallel-plate flow chambers. The mean level of NETosis in healthy volunteers was 2.7–6.7% (95% CI). Among the ET patients, there was no statistically significant difference in NETosis level between those with mutations in CALR (19–43%), JAK2 (22–58%), and TN ones (6–27%). Patients with secondary thrombocytosis also had an elevated level of NETosis (8–66%). The velocity of neutrophil chemotaxis was significantly increased in all patients, in particular for those with mutations in CALR. These data reveal a major shift in the neutrophil activity in ET and suggest that the immunomorphological techniques presented here may allow reproducible and widely available characterization of neutrophil status.


  • Open Access

    Characteristics of the functional state of peripheral blood neutrophils in patients with luminal breast cancer

    by Julia Jessica D. Korobkina, Ekaterina-Iva A. Adamanskaya, Natalya I. Polshina, Sofia V. Galkina, Timur I. Kadyrov, Nikolay P. Gorbunov, Alexey V. Sokolov, Lyudmila G. Zhukova, Anastasia N. Sveshnikova

    BACKGROUND: Neutrophils are essential in tumor growth, and their functional state can serve as a prognostic biomarker. However, the functional characteristics of peripheral blood neutrophils, such as chemotaxis and predisposition to NETosis, in female patients with luminal breast cancer have not been sufficiently explored. Studying these parameters may provide new insights into the mechanisms of disease progression and response to therapy. AIM: This work aimed to analyze the chemotactic activity of neutrophils and predisposition to NETosis in blood samples of female patients with locally advanced luminal breast cancer undergoing treatment (neoadjuvant chemotherapy) at the Loginov Moscow Clinical Scientific Center. METHODS: The study was conducted on blood samples from six patients with stage 3 luminal B, HER2-negative breast cancer before and 2 months after the start of antitumor therapy. Blood samples from healthy adult volunteers were used as controls. The work was performed using fluorescence microscopy methods for neutrophil chemotaxis with the growth of blood clots and the number of extracellular DNA traps of neutrophils by reaction with Hoechst 33342 and antibodies against myeloperoxidase and neutrophil elastase in smears of blood plasma rich in leukocytes. RESULTS: Before the start of neoadjuvant therapy, the level of NETosis is significantly increased (30% ± 14% versus 4.6% ± 3.4% in healthy donors), whereas most female patients undergoing therapy experience its reduction (17% ± 17%). The speed of neutrophil movement is increased in some female patients (0.17 ± 0.06 versus 0.113 ± 0.009 μm/s in healthy donors) and goes down during therapy (0.10 ± 0.03 μm/s). At the same time, the number of neutrophils associated with blood clots decreases during therapy (25 ± 18 versus 61 ± 23) even in patients with neutrophilia. CONCLUSION: It has been demonstrated for the first time that in female patients with luminal B, HER2-negative breast cancer, the neutrophil chemotaxis speed deviates from the standard; at the same time, their adhesion is reduced, and peripheral blood neutrophils are significantly more predisposed to NETosis than in healthy donors.


  • Open Access

    Intracellular signaling involved in the programmed neutrophil cell death leading to the release of extracellular DNA traps in thrombus formation

    by A. N. Sveshnikova, E. A. Adamanskaya, Yu.-D. D. Korobkina, M. A. Panteleev

    The formation of extracellular DNA traps by neutrophils, or NETs (neutrophil extracellular traps) plays an essential role in many pathological processes related to hematological, oncological, and immunological diseases. This mechanism of the programmed cell death of neutrophils and other leukocytes appears to be also involved in the pathogenesis of thrombosis and thrombotic complications of a variety of disorders. In this review, we discuss the pathways of intracellular signaling leading to neutrophil activation in thrombosis and hemostasis. Even though the biochemical reactions in a cell are quite well investigated, the regulation of activity of specific proteins involved in NETosis, such as NADPH oxidase (NOX) and protein-arginine deiminase (PAD4), requires further investigation. Current approaches to the pharmacological modulation of NETosis are also specifically addressed here.


  • Open Access

    Conditions for the implementation of the phenomenon of programmed death of neutrophils with the appearance of DNA extracellular traps during thrombus formation

    by A. N. Sveshnikova, E. A. Adamanskaya, M. A. Panteleev

    The formation of DNA extracellular traps of neutrophils (NET-osis) is a mechanism of programmed cell death of leukocytes, which initially has antibacterial and antifungal functions. The ability of neutrophils to become activated upon contact with activated platelets and, in turn, to activate the contact coagulation pathway via DNA traps plays a central role in venous thrombosis and disseminated intravascular coagulation in COVID-19. At the same time, the intracellular signaling that controls NET-osis is extremely poorly understood even for the simplest cases, when this process is caused by lipopolysaccharides of the bacterial cell wall. In this review, we consider the case of NET-osis in thrombosis, for which there are even more questions. We focused on the conditions for NET-osis observation and features in different scenarios.